genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Insilico Medicine
Artificial Intelligence
Insilico Targets MTAP Deleted Cancers with AI-Designed Candidate
Cancer
AACR 2024: Insilico Medicine to Present Preclinical Data for AI-Generated Cancer Drugs
Artificial Intelligence
GTC 2024: Nvidia Highlights AI ‘Revolution’ in Drug Discovery, Genomics
Artificial Intelligence
Insilico Doses First Patient with AI-Designed IBD Treatment
Artificial Intelligence
StockWatch: Insilico CEO Breaks Down Exelixis Deal
Artificial Intelligence
Insilico’s AI Tackles Lysosomal Storage Disorder, IPF Drug Gets Inhalable Formula
Artificial Intelligence
Insilico’s AI Candidate for IPF Doses First Patient in Phase II
Artificial Intelligence
Alex Zhavoronkov Aims to Take Over the Drug Development World with AI
Artificial Intelligence
AI Takes On Drug Discovery
Artificial Intelligence
Insilico Gains FDA’s First Orphan Drug Designation for AI Candidate
Scroll Up